Nanoscope in the News
-
Eye on the Cure Podcast Episode #46 : Aaron Osborne, MD, Chief Medical Officer and Chief Development Office of Nanoscope Therapeutics
May 24, 2023 by Nanoscope Therapeutics
-
Clinical Trials Arena : Nanoscope reveals key efficacy data from Phase IIb ophthalmology trial
April 28, 2023 by Nanoscope Therapeutics
-
Ophthalmology Times : Nanoscope Therapeutics presents results from phase 2b RESTORE trial of MCO-010 for treatment of retinitis pigmentosa
April 28, 2023 by Nanoscope Therapeutics
-
Global Genes: Nanoscope Reports Positive Topline Results from Phase 2b Trial of MCO-010 for the Treatment of Retinitis Pigmentosa
April 10, 2023 by Nanoscope Therapeutics
-
Clinical Trials Arena: Nanoscope’s Gene Therapy Nabs Phase II Win in Retinitis Pigmentosa
March 30, 2023 by Nanoscope Therapeutics
-
Fierce Biotech: Nanoscope’s Phase 2Win for Gene Therapy Shows Potential of Light-sensitive Approach to Eye Disease
March 30, 2023 by Nanoscope Therapeutics
-
The Future 50 in Dallas-Fort Worth 2023: Meet the Game-Changing Disruptors Driving Innovation and Impace
March 17, 2023 by Nanoscope Therapeutics
-
Modern Retina: Nanoscope Therapeutics announces WHO selection of ‘sonpiretigene isteparvovec’ as international nonproprietary name for MCO-010
March 1, 2023 by Nanoscope Therapeutics
-
CGT Live: 10 Cell and Gene Therapies to Watch in 2023
January 25, 2023 by Nanoscope Therapeutics
-
Modern Retina: FDA grants fast track designation to Nanoscope Therapeutics for MCO-010 for the treatment of retinitis pigmentosa
October 18, 2022 by Nanoscope Therapeutics
-
Ocular Surgery News: Retinitis Pigmentosa Treatment Receives Fast Track Designation
October 18, 2022 by Nanoscope Therapeutics
-
Euretina Congress Daily: Making Headway in the Battle Against Inherited Retinal Disease
September 15, 2022 by Nanoscope Therapeutics
-
Ophthalmology Times: Enrollment Complete in STARLIGHT Phase 2 Clinical Trial of MCO-010 Optogenetic Gene Therapy for Stargardt Disease
September 13, 2022 by Nanoscope Therapeutics
-
Meet the 43 Finalists for the 2022 Tech Titans Awards
September 9, 2022 by Nanoscope Therapeutics
-
CityBiz: TechFW Member Nanoscope Starts Second Stage 2 Trial
July 26, 2022 by Nanoscope Therapeutics
-
CGT Live: Nanoscope Gene Therapy Continues Progress in Stargardt Disease
July 26, 2022 by Nanoscope Therapeutics
-
Ocular Surgery News: Phase 2 gene therapy trial for Stargardt disease underway
July 26, 2022 by Wilson PJ
-
Ophthalmology Times: Nanoscope Therapeutics announces first patient dosed in STARLIGHT Phase 2 clinical trial of MCO-010 optogenetic gene therapy for Stargardt disease
July 25, 2022 by Nanoscope Therapeutics
-
Retina Synthesis: Optogenetics Interview with Samarendra Mohanty, PhD and Charles Wykoff, MD
May 3, 2022 by Nanoscope Therapeutics
-
Healio: Gene therapy platform for Stargardt macular degeneration receives IND clearance
January 25, 2022 by Nanoscope Therapeutics